Bartlett, JB;
Michael, A;
Clarke, IA;
Dredge, K;
Nicholson, S;
Kristeleit, H;
Polychronis, A;
Pandha, H;
Muller, GW;
Stirling, DI;
et al.
Bartlett, JB; Michael, A; Clarke, IA; Dredge, K; Nicholson, S; Kristeleit, H; Polychronis, A; Pandha, H; Muller, GW; Stirling, DI; Zeldis, J; Dalgleish, AG
(2004)
Phase 1 study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
BRITISH JOURNAL OF CANCER, 90 (5).
955 - 961 (7).
ISSN 0007-0920
https://doi.org/10.1038/sj.bjc.6601579
SGUL Authors: Dalgleish, Angus George
| Item Type: |
Article
|
| Additional Information: |
PubMed ID: 14997189 |
| Keywords: |
Adolescent, Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Cytokines, Female, Fibroblast Growth Factor 2, Humans, Immunization, Male, Maximum Tolerated Dose, Melanoma, Middle Aged, Neoplasms, Safety, Skin Neoplasms, T-Lymphocytes, Thalidomide, Vascular Endothelial Growth Factor A, Science & Technology, Life Sciences & Biomedicine, Oncology, phase 1, CC-5013, thalidomide, immunomodulation, cytokines, T-cell activation, REFRACTORY MULTIPLE-MYELOMA, COLONY-STIMULATING FACTOR, LOW-DOSE THALIDOMIDE, CROHNS-DISEASE, CYTOKINE PRODUCTION, AGENT THALIDOMIDE, DRUG-RESISTANCE, DOUBLE-BLIND, THERAPY, TRIAL, phase 1, CC-5013, thalidomide, immunomodulation, cytokines, T-cell activation |
| SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
| Journal or Publication Title: |
BRITISH JOURNAL OF CANCER |
| ISSN: |
0007-0920 |
| Related URLs: |
|
| Dates: |
| Date | Event |
|---|
| 8 March 2004 | Published |
|
| Web of Science ID: |
WOS:000220846800004 |
  |
Download EPMC Full text (PDF)
|
|
Download EPMC Full text (HTML)
|
| URI: |
http://sgultest.da.ulcc.ac.uk/id/eprint/52 |
| Publisher's version: |
https://doi.org/10.1038/sj.bjc.6601579 |
Statistics
Item downloaded times since 06 Dec 2012.
Actions (login required)
 |
Edit Item |
